Update On The Teva Copaxone EU Case. The EU Commission Issues A Statement Of Objections Against Teva Over Alleged Anti-Competitive Conduct Consisting Of Misuse Of Divisional Patents And A Disparagement Campaign Against
US states accuse Teva and other drugmakers of colluding to inflate prices over 1,000%
Pfizer and Teva face new drug delay action - Global Competition Review
Gilead And Teva's HIV Antitrust Trial Begins
Teva must face government's kickback claims over Copaxone - judge | Reuters
Teva Class Action Claims Company Suppressed Competition For Generic Version Of MS Drug Copaxone - Top Class Actions
Teva Pharm expects U.S. opioid case settlements to cost $2.6 bln | Reuters
Biden admin urges Supreme Court to hear 'skinny labels' case between Teva, GSK | Reuters
Judge Narrows Antitrust Case Against Teva Over Gilead HIV Drugs -
Teva asks high court to overturn recent GSK skinny label loss
Teva Q1 2023 Earnings: A Mix Of Challenges And Opportunities | Seeking Alpha
Teva stocks fall after company said named in US price-fixing drug 'cartel' probe | The Times of Israel
Ranbaxy, Teva settle US anti-competition case | Mint
Copaxone not dead yet as Teva appeal lives on | Evaluate
Teva Under Suspicion On Practices To Stave Off Copaxone Competition
Gilead, Teva and J&J's HIV antitrust case inches closer to trial
Teva Is Easy Pill to Swallow - WSJ
Teva Hit With New Lawsuit Over Proposed Korlym Drug Copy
Teva Settles Arkansas Price-Fixing Case for $931K | Arkansas Business News | ArkansasBusiness.com
Violetta Meli on LinkedIn: Update on the Teva Copaxone EU case. The EU Commission issues a Statement…
Teva Settles Cephalon Generics Case With F.T.C. for $1.2 Billion - The New York Times
Teva slide could draw vultures but it won't be easy prey | The Times of Israel
Teva settles Cephalon case with FTC for $1.2 billion over sleep drug - The Boston Globe
Case studies in Strategy: Teva
Statement by Executive Vice-President Margrethe Vestager on the Commission decision to fine Teva and Cephalon €60.5 million for delaying entry of cheaper generic medicine - PubAffairs Bruxelles
